Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-03 4:58 pm Purchase |
2022-12-21 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,448,275 7.000% |
3,448,275 (New Position) |
Filing History |
| 2022-11-02 09:35 am Purchase |
2022-10-21 | 13G | Biohaven Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,840,338 5.600% |
3,840,338 (New Position) |
Filing History |
| 2022-07-21 5:44 pm Purchase |
2022-07-11 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT LLC | 6,269,300 10.200% |
6,269,300 (New Position) |
Filing History |
| 2022-06-27 4:42 pm Purchase |
2022-06-16 | 13G | Arcellx, Inc. ACLX |
SUVRETTA CAPITAL MANAGEMENT LLC | 2,470,559 5.800% |
2,470,559 (New Position) |
Filing History |
| 2022-06-13 4:32 pm Purchase |
2022-06-03 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT LLC | 314,180 5.200% |
314,180 (New Position) |
Filing History |
| 2022-05-02 5:15 pm Purchase |
2022-04-21 | 13G | Chimerix, Inc. CMRX |
SUVRETTA CAPITAL MANAGEMENT LLC | 4,948,000 5.700% |
4,948,000 (New Position) |
Filing History |
| 2022-02-11 5:54 pm Unchanged |
2021-12-31 | 13G | Katapult Holdings, Inc. KPLT |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:46 pm Unchanged |
2021-12-31 | 13G | Archer Aviation Inc. ACHR |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:36 pm Unchanged |
2021-12-31 | 13G | Matterport, Inc. MTTR |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:27 pm Sale |
2021-12-31 | 13G | TPG Pace Beneficial Finance Corp. TPGY |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-2,075,000 (Position Closed) |
Filing History |
| 2022-02-11 5:25 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT LLC | 2,638,775 7.200% |
586,417 (+28.57%) |
Filing History |
| 2022-02-11 5:20 pm Purchase |
2021-12-31 | 13G | Solid Biosciences Inc. SLDB |
SUVRETTA CAPITAL MANAGEMENT LLC | 419,146 5.700% |
20,867 (+5.24%) |
Filing History |
| 2022-02-11 5:17 pm Purchase |
2021-12-31 | 13G | POINT Biopharma Global Inc. PNT |
SUVRETTA CAPITAL MANAGEMENT LLC | 2,672,863 3.000% |
2,672,863 (New Position) |
Filing History |
| 2022-02-11 5:14 pm Sale |
2021-12-31 | 13G | Fintech Acquisition Corp. V FTCV |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,901,890 (Position Closed) |
Filing History |
| 2022-02-11 5:09 pm Sale |
2021-12-31 | 13G | Otonomy, Inc. OTIC |
SUVRETTA CAPITAL MANAGEMENT LLC | 5,993,689 9.990% |
-25,189 (-0.42%) |
Filing History |
| 2022-02-11 5:09 pm Unchanged |
2021-12-31 | 13G | Berkshire Grey, Inc. BGRY |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:03 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT LLC | 1,746,300 7.100% |
449,848 (+34.70%) |
Filing History |
| 2022-02-11 4:55 pm Purchase |
2021-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,572,419 5.400% |
69,000 (+1.97%) |
Filing History |
| 2022-02-11 4:55 pm Sale |
2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-383,880 (Position Closed) |
Filing History |
| 2022-02-11 4:49 pm Purchase |
2021-12-31 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT LLC | 2,473,795 5.400% |
65,400 (+2.72%) |
Filing History |